The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Repros Therapeutics Inc

Nasdaq: RPRX
Last

(U.S.) $0.92

Today's change+0.02 +2.22%
Updated February 9 4:00 PM -5GMT. Delayed by at least 15 minutes.
 

Repros Therapeutics Inc

Nasdaq: RPRX
Last

(U.S.) $0.92

Today's change+0.02 +2.22%
Updated February 9 4:00 PM -5GMT. Delayed by at least 15 minutes.

Repros Therapeutics Inc up sharply

Repros Therapeutics Inc closed up sharply Tuesday, rallying (U.S.)$0.02 or 2.22% to (U.S.)$0.92. Over the last five days, shares have lost 8.91% and sit 3.37% above their 52-week low. This security has underperformed the S&P 500 by 79.28% during the last year.

Key company metrics

  • Open(U.S.) $0.91
  • Previous close(U.S.) $0.90
  • High(U.S.) $0.96
  • Low(U.S.) $0.89
  • Bid / Ask(U.S.) $0.70 / (U.S.) $0.96
  • YTD % change-23.97%
  • Volume178,356
  • Average volume (10-day)186,164
  • Average volume (1-month)291,201
  • Average volume (3-month)748,569
  • 52-week range(U.S.) $0.89 to (U.S.) $10.05
  • Beta-0.31
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.27
Updated February 9 4:00 PM -5GMT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue--------
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense7898
Selling / general / administrative2323
Research & development5565
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-7-8-9-8
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-7-8-9-8
Income after tax-7-8-9-8
Income tax, total--------
Net income-7-8-9-8
Total adjustments to net income--------
Net income before extra. items-7-8-9-8
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-7-8-9-8
Inc. avail. to common incl. extra. items-7-8-9-8
Diluted net income-7-8-9-8
Dilution adjustment--0----
Diluted weighted average shares24242424
Diluted EPS excluding extraordinary itemsvalue per share-0.27-0.32-0.35-0.33
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.27-0.32-0.35-0.33